Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
EWTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-254792, 333-262953 and 333-271836) on Form S-8 and (Nos. 333-264083 and 333-276595) on Form S-3 of our report dated February 22, 2024, with respect to the financial statements of Edgewise Therapeutics, Inc.
/s/ KPMG LLP
Denver, Colorado
February 22, 2024